is it dangerous to take glp 1 The promise and peril of GLP-1 agonists: What we do (and don't) know as of August 2024 FAQ of the Month: Is

Description

Keywords GLP-1 Agonists SGLT-2 Inhibitors Diabetes Mellitus Chronic Kidney Disease Liver Transplantation Introduction Despite the life-saving intervention of liver transplantation for patients with ESLD (end-stage liver disease), the success of transplantation is compromised often by post-transplant complications, particularly diabetes mellitus and chronic kidney disease (CKD)

Biochem Biophys Res Commun 499(3):499505

In such cases, GLP-1 hormone can help contribute to glucose control by stimulating glucose-dependent insulin release, reducing glucagon secretion, slowing gastric emptying, and eventually enhancing satiety

At clinics like LA VIE MD, a maintenance consultation includes: Body composition and metabolic review

Rare patients continue to have mild episodic hypoglycemia despite continuous G-tube feeding, which may improve with the addition of carbohydrates to the tube-feeding formula